What Has Been The Evolution of the Cancer Cachexia Market in Recent Years?
The cancer cachexia market has seen considerable growth due to a variety of factors.
• The cancer cachexia market has seen strong growth in recent years. It will increase from $2.47 billion in 2024 to $2.62 billion in 2025, at a compound annual growth rate (CAGR) of 6.4%.
This growth can be attributed to a better understanding of cancer biology, the rising prevalence of cancer, an aging population, a focus on patient-centered care, expanded treatment options, and heightened healthcare provider awareness.
What Are the Future Growth Projections for the Cancer Cachexia Market?
The cancer cachexia market is expected to maintain its strong growth trajectory in upcoming years.
• The cancer cachexia market is anticipated to reach $3.33 billion by 2029, growing at a CAGR of 6.2%.
Factors contributing to growth include increased awareness of cachexia management, a growing elderly population, the adoption of new treatments, rising healthcare expenditures, and supportive government policies. Key trends include expanded research and development efforts, more treatment options, better diagnosis rates, novel treatment modalities, and advancements in supportive care.
What Are The Core Factors Supporting Growth In The Cancer Cachexia Market?
The growing prevalence of cancer is expected to spur the growth of the cancer cachexia market. With cancer rates rising due to factors like aging and lifestyle changes, the demand for treatments addressing cancer cachexia (muscle wasting) is increasing. The National Cancer Institute projects 2 million new cancer cases in the U.S. in 2024, pushing the market for cancer cachexia treatments.
What Are The Major Segments Within The Global Cancer Cachexia Market?
The cancer cachexia market covered in this report is segmented –
1) By Therapeutics: Progestogens, Corticosteroids, Combination Therapies, Other Therapeutics
2) By Mechanism Of Action: Appetite Stimulators, Weight Loss Stabilizers, Other Mechanisms Of Actions
3) By Distribution Channel: Hospital Stores, Retail Pharmacy Stores, Online Pharmacies
Subsegments:
1) By Progestogens: Megestrol Acetate, Medroxyprogesterone Acetate, Hydroxyprogesterone Caproate
2) By Corticosteroids: Dexamethasone, Prednisolone, Methylprednisolone
3) By Combination Therapies: Progestogens + Corticosteroids, Progestogens + Anabolic Agents, Corticosteroids + Anabolic Agents
4) By Other Therapeutics: Anabolic Agents, Appetite Stimulants, Anti-inflammatory Drugs, Nutritional Supplements
Pre-Book The Cancer Cachexia Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Cancer Cachexia Market?
In the cancer cachexia market, companies are developing targeted treatments such as monoclonal antibodies to improve body weight and muscle mass in patients with cachexia. For instance, in September 2024, Pfizer Inc., a US-based pharmaceutical company, announced positive Phase 2 trial results for Ponsegromab, a monoclonal antibody targeting GDF-15 in cancer cachexia patients. The trial showed significant improvements in body weight, muscle mass, appetite, and physical activity, and Pfizer plans to conduct further studies in 2025 to explore Ponsegromab’s potential in treating cancer cachexia.
Who Are the Key Players In The Cancer Cachexia Market?
Major companies operating in the cancer cachexia market are:
• Pfizer Inc.
• Merck & Co. Inc.
• AbbVie Inc.
• Bayer AG
• Sanofi SA
• Bristol Myers Squibb Company
• AstraZeneca plc
• Novartis International AG
• Fresenius SE & Co. KGaA
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company
• Eli Lilly and Company
• Boehringer Ingelheim International GmbH
• Teva Pharmaceutical Industries Ltd.
• Astellas Pharma Inc.
• Daiichi Sankyo Company Limited
• Sun Pharmaceutical Industries Ltd.
• Perrigo Company plc
• Kyowa Kirin Co. Ltd.
• Hikma Pharmaceuticals plc
• Endo International plc
• Aspen Pharmacare Holdings Limited
• Lupin Limited
• Mallinckrodt plc
• Akorn Inc.
• Aeterna Zentaris
• XBiotech Inc.
What Is The Most Dominant Region In The Cancer Cachexia Market?
North America was the largest region in the cancer cachexia market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer cachexia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
